Clinical Trial NCT05741346

Back to all clinical trials

Trial

BioCryst – BCX9930-205 2021-006776-17 (NCT05741346)

Clinical trial ID

NCT05741346

Drug name

BCX9930

Company:

BioCryst

Drug trade name

---

Clinicaltrials.gov

Learn more

Phase of study

2

Current status

Recruiting

Start

01/2023

Substance

---

Research question

Continued treatment for patients already receiving this drug

Delivery method of drug

oral

Frequency

2 x daily

Clinical trial locations

France Hungary Korea Malaysia Spain UK